TY - JOUR AU - Cremers, S. C. AU - Pillai, G. AU - Papapoulos, S. E. PY - 2005 DA - 2005// TI - Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis JO - Clin Pharmacokinet VL - 44 UR - https://doi.org/10.2165/00003088-200544060-00001 DO - 10.2165/00003088-200544060-00001 ID - Cremers2005 ER - TY - JOUR AU - Rogers, M. J. AU - Gordon, S. AU - Benford, H. L. AU - Coxon, F. P. AU - Luckman, S. P. AU - Monkkonen, J. AU - Frith, J. C. PY - 2000 DA - 2000// TI - Cellular and molecular mechanisms of action of bisphosphonates JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-L DO - 3.0.CO;2-L ID - Rogers2000 ER - TY - JOUR AU - Rogers, M. J. AU - Watts, D. J. AU - Russell, R. G. PY - 1997 DA - 1997// TI - Overview of bisphosphonates JO - Cancer VL - 80 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Rogers1997 ER - TY - JOUR AU - Civitelli, R. AU - Napoli, N. AU - Armamento-Villareal, R. PY - 2007 DA - 2007// TI - Use of intravenous bisphosphonates in osteoporosis JO - Curr Osteoporos Rep VL - 5 UR - https://doi.org/10.1007/BF02938617 DO - 10.1007/BF02938617 ID - Civitelli2007 ER - TY - JOUR AU - Goffinet, M. AU - Thoulouzan, M. AU - Pradines, A. AU - Lajoie-Mazenc, I. AU - Weinbaum, C. AU - Faye, J. C. AU - Seronie-Vivien, S. PY - 2006 DA - 2006// TI - Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells JO - BMC Cancer VL - 6 UR - https://doi.org/10.1186/1471-2407-6-60 DO - 10.1186/1471-2407-6-60 ID - Goffinet2006 ER - TY - JOUR AU - Kanis, J. A. PY - 1995 DA - 1995// TI - Bone and cancer: pathophysiology and treatment of metastases JO - Bone VL - 17 UR - https://doi.org/10.1016/8756-3282(95)00194-I DO - 10.1016/8756-3282(95)00194-I ID - Kanis1995 ER - TY - JOUR AU - Mundy, G. R. PY - 1987 DA - 1987// TI - Bone resorption and turnover in health and disease JO - Bone VL - 8 ID - Mundy1987 ER - TY - JOUR AU - Cohen, S. B. PY - 2004 DA - 2004// TI - An update on bisphosphonates JO - Curr Rheumatol Rep VL - 6 UR - https://doi.org/10.1007/s11926-004-0084-2 DO - 10.1007/s11926-004-0084-2 ID - Cohen2004 ER - TY - JOUR AU - Marx, R. E. PY - 2003 DA - 2003// TI - Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic JO - J Oral Maxillofac Surg VL - 61 UR - https://doi.org/10.1016/S0278-2391(03)00720-1 DO - 10.1016/S0278-2391(03)00720-1 ID - Marx2003 ER - TY - JOUR AU - Olson, K. B. AU - Hellie, C. M. AU - Pienta, K. J. PY - 2005 DA - 2005// TI - Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid JO - Urology VL - 66 UR - https://doi.org/10.1016/j.urology.2005.03.028 DO - 10.1016/j.urology.2005.03.028 ID - Olson2005 ER - TY - JOUR AU - Santini, D. AU - Vespasiani Gentilucci, U. AU - Vincenzi, B. AU - Picardi, A. AU - Vasaturo, F. AU - La Cesa, A. AU - Onori, N. AU - Scarpa, S. AU - Tonini, G. PY - 2003 DA - 2003// TI - The antineoplastic role of bisphosphonates: from basic research to clinical evidence JO - Ann Oncol VL - 14 UR - https://doi.org/10.1093/annonc/mdg401 DO - 10.1093/annonc/mdg401 ID - Santini2003 ER - TY - JOUR AU - Wood, J. AU - Bonjean, K. AU - Ruetz, S. AU - Bellahcene, A. AU - Devy, L. AU - Foidart, J. M. AU - Castronovo, V. AU - Green, J. R. PY - 2002 DA - 2002// TI - Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid JO - J Pharmacol Exp Ther VL - 302 UR - https://doi.org/10.1124/jpet.102.035295 DO - 10.1124/jpet.102.035295 ID - Wood2002 ER - TY - JOUR AU - Badros, A. AU - Weikel, D. AU - Salama, A. AU - Goloubeva, O. AU - Schneider, A. AU - Rapoport, A. AU - Fenton, R. AU - Gahres, N. AU - Sausville, E. AU - Ord, R. AU - Meiller, T. PY - 2006 DA - 2006// TI - Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.2465 DO - 10.1200/JCO.2005.04.2465 ID - Badros2006 ER - TY - JOUR AU - Bagan, J. V. AU - Jimenez, Y. AU - Murillo, J. AU - Hernandez, S. AU - Poveda, R. AU - Sanchis, J. M. AU - Diaz, J. M. AU - Scully, C. PY - 2006 DA - 2006// TI - Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases JO - Oral Oncol VL - 42 UR - https://doi.org/10.1016/j.oraloncology.2005.08.001 DO - 10.1016/j.oraloncology.2005.08.001 ID - Bagan2006 ER - TY - JOUR AU - Bamias, A. AU - Kastritis, E. AU - Bamia, C. AU - Moulopoulos, L. A. AU - Melakopoulos, I. AU - Bozas, G. AU - Koutsoukou, V. AU - Gika, D. AU - Anagnostopoulos, A. AU - Papadimitriou, C. AU - Terpos, E. AU - Dimopoulos, M. A. PY - 2005 DA - 2005// TI - Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.02.8670 DO - 10.1200/JCO.2005.02.8670 ID - Bamias2005 ER - TY - JOUR AU - Khosla, S. AU - Burr, D. AU - Cauley, J. AU - Dempster, D. W. AU - Ebeling, P. R. AU - Felsenberg, D. AU - Gagel, R. F. AU - Gilsanz, V. AU - Guise, T. AU - Koka, S. AU - McCauley, L. K. AU - McGowan, J. AU - McKee, M. D. AU - Mohla, S. AU - Pendrys, D. G. AU - Raisz, L. G. AU - Ruggiero, S. L. AU - Shafer, D. M. AU - Shum, L. AU - Silverman, S. L. AU - Van Poznak, C. H. AU - Watts, N. AU - Woo, S. B. AU - Shane, E. PY - 2007 DA - 2007// TI - Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research JO - J Bone Miner Res VL - 22 UR - https://doi.org/10.1359/jbmr.0707onj DO - 10.1359/jbmr.0707onj ID - Khosla2007 ER - TY - JOUR AU - Mavrokokki, T. AU - Cheng, A. AU - Stein, B. AU - Goss, A. PY - 2007 DA - 2007// TI - Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia JO - J Oral Maxillofac Surg VL - 65 UR - https://doi.org/10.1016/j.joms.2006.10.061 DO - 10.1016/j.joms.2006.10.061 ID - Mavrokokki2007 ER - TY - JOUR AU - Woo, S. B. AU - Hellstein, J. W. AU - Kalmar, J. R. PY - 2006 DA - 2006// TI - Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws JO - Ann Intern Med VL - 144 UR - https://doi.org/10.7326/0003-4819-144-10-200605160-00009 DO - 10.7326/0003-4819-144-10-200605160-00009 ID - Woo2006 ER - TY - JOUR AU - Aragon-Ching, J. B. AU - Ning, Y. M. AU - Chen, C. C. AU - Latham, L. AU - Guadagnini, J. P. AU - Gulley, J. L. AU - Arlen, P. M. AU - Wright, J. J. AU - Parnes, H. AU - Figg, W. D. AU - Dahut, W. L. PY - 2009 DA - 2009// TI - Higher incidence of osteonecrosis of the jaw (ONJ) in patients with metastatic castration resistant prostate cancer treated with anti-angiogenic agents JO - Cancer Invest VL - 27 UR - https://doi.org/10.1080/07357900802208608 DO - 10.1080/07357900802208608 ID - Aragon-Ching2009 ER - TY - JOUR AU - Boonyapakorn, T. AU - Schirmer, I. AU - Reichart, P. A. AU - Sturm, I. AU - Massenkeil, G. PY - 2008 DA - 2008// TI - Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies JO - Oral Oncol VL - 44 UR - https://doi.org/10.1016/j.oraloncology.2007.11.012 DO - 10.1016/j.oraloncology.2007.11.012 ID - Boonyapakorn2008 ER - TY - JOUR AU - Walter, C. AU - Al-Nawas, B. AU - Grotz, K. A. AU - Thomas, C. AU - Thuroff, J. W. AU - Zinser, V. AU - Gamm, H. AU - Beck, J. AU - Wagner, W. PY - 2008 DA - 2008// TI - Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate JO - Eur Urol VL - 54 UR - https://doi.org/10.1016/j.eururo.2008.06.070 DO - 10.1016/j.eururo.2008.06.070 ID - Walter2008 ER - TY - JOUR AU - Fleisch, H. PY - 2003 DA - 2003// TI - Bisphosphonates in osteoporosis JO - Eur Spine J VL - 12 UR - https://doi.org/10.1007/s00586-003-0622-z DO - 10.1007/s00586-003-0622-z ID - Fleisch2003 ER - TY - JOUR AU - Bilezikian, J. P. PY - 2006 DA - 2006// TI - Osteonecrosis of the jaw-do bisphosphonates pose a risk? JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMp068157 DO - 10.1056/NEJMp068157 ID - Bilezikian2006 ER - TY - JOUR AU - Chen, T. AU - Berenson, J. AU - Vescio, R. AU - Swift, R. AU - Gilchick, A. AU - Goodin, S. AU - LoRusso, P. AU - Ma, P. AU - Ravera, C. AU - Deckert, F. AU - Schran, H. AU - Seaman, J. AU - Skerjanec, A. PY - 2002 DA - 2002// TI - Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases JO - J Clin Pharmacol VL - 42 UR - https://doi.org/10.1177/009127002762491316 DO - 10.1177/009127002762491316 ID - Chen2002 ER - TY - JOUR AU - Coxon, J. P. AU - Oades, G. M. AU - Kirby, R. S. AU - Colston, K. W. PY - 2004 DA - 2004// TI - Zoledronic acid induces apoptosis and inhibits adhesion to mineralized matrix in prostate cancer cells via inhibition of protein prenylation JO - BJU Int VL - 94 UR - https://doi.org/10.1111/j.1464-4096.2004.04831.x DO - 10.1111/j.1464-4096.2004.04831.x ID - Coxon2004 ER - TY - JOUR AU - Skerjanec, A. AU - Berenson, J. AU - Hsu, C. AU - Major, P. AU - Miller, W. H. AU - Ravera, C. AU - Schran, H. AU - Seaman, J. AU - Waldmeier, F. PY - 2003 DA - 2003// TI - The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function JO - J Clin Pharmacol VL - 43 UR - https://doi.org/10.1177/0091270002239824 DO - 10.1177/0091270002239824 ID - Skerjanec2003 ER - TY - JOUR AU - Smith, M. R. PY - 2003 DA - 2003// TI - Antitumor activity of bisphosphonates JO - Clin Cancer Res VL - 9 ID - Smith2003 ER - TY - JOUR AU - Scheper, M. A. AU - Badros, A. AU - Salama, A. R. AU - Warburton, G. AU - Cullen, K. J. AU - Weikel, D. S. AU - Meiller, T. F. PY - 2009 DA - 2009// TI - A novel bioassay model to determine clinically significant bisphosphonate levels JO - Support Care Cancer VL - 17 UR - https://doi.org/10.1007/s00520-009-0710-7 DO - 10.1007/s00520-009-0710-7 ID - Scheper2009 ER - TY - JOUR AU - Agis, H. AU - Blei, J. AU - Watzek, G. AU - Gruber, R. PY - 2010 DA - 2010// TI - Is zoledronate toxic to human periodontal fibroblasts? JO - J Dent Res VL - 89 UR - https://doi.org/10.1177/0022034509354298 DO - 10.1177/0022034509354298 ID - Agis2010 ER - TY - JOUR AU - Badros, A. AU - Terpos, E. AU - Katodritou, E. AU - Goloubeva, O. AU - Kastritis, E. AU - Verrou, E. AU - Zervas, K. AU - Baer, M. R. AU - Meiller, T. AU - Dimopoulos, M. A. PY - 2008 DA - 2008// TI - Natural history of osteonecrosis of the jaw in patients with multiple myeloma JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2008.16.9300 DO - 10.1200/JCO.2008.16.9300 ID - Badros2008 ER - TY - JOUR AU - Reid, I. R. AU - Bolland, M. J. AU - Grey, A. B. PY - 2007 DA - 2007// TI - Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? JO - Bone VL - 41 UR - https://doi.org/10.1016/j.bone.2007.04.196 DO - 10.1016/j.bone.2007.04.196 ID - Reid2007 ER - TY - JOUR AU - Scheper, M. A. AU - Badros, A. AU - Chaisuparat, R. AU - Cullen, K. J. AU - Meiller, T. F. PY - 2009 DA - 2009// TI - Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis JO - Br J Haematol VL - 144 UR - https://doi.org/10.1111/j.1365-2141.2008.07504.x DO - 10.1111/j.1365-2141.2008.07504.x ID - Scheper2009 ER - TY - JOUR AU - Ruggiero, S. L. AU - Drew, S. J. PY - 2007 DA - 2007// TI - Osteonecrosis of the jaws and bisphosphonate therapy JO - J Dent Res VL - 86 UR - https://doi.org/10.1177/154405910708601101 DO - 10.1177/154405910708601101 ID - Ruggiero2007 ER - TY - JOUR AU - Farrugia, M. C. AU - Summerlin, D. J. AU - Krowiak, E. AU - Huntley, T. AU - Freeman, S. AU - Borrowdale, R. AU - Tomich, C. PY - 2006 DA - 2006// TI - Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates JO - Laryngoscope VL - 116 UR - https://doi.org/10.1097/01.mlg.0000187398.51857.3c DO - 10.1097/01.mlg.0000187398.51857.3c ID - Farrugia2006 ER - TY - JOUR AU - Bukowski, J. F. AU - Dascher, C. C. AU - Das, H. PY - 2005 DA - 2005// TI - Alternative bisphosphonate targets and mechanisms of action JO - Biochem Biophys Res Commun VL - 328 UR - https://doi.org/10.1016/j.bbrc.2004.11.075 DO - 10.1016/j.bbrc.2004.11.075 ID - Bukowski2005 ER - TY - JOUR AU - Sedghizadeh, P. P. AU - Kumar, S. K. AU - Gorur, A. AU - Schaudinn, C. AU - Shuler, C. F. AU - Costerton, J. W. PY - 2008 DA - 2008// TI - Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy JO - J Oral Maxillofac Surg VL - 66 UR - https://doi.org/10.1016/j.joms.2007.11.035 DO - 10.1016/j.joms.2007.11.035 ID - Sedghizadeh2008 ER - TY - JOUR AU - McGuigan, J. A. AU - Kay, J. W. AU - Elder, H. Y. PY - 2006 DA - 2006// TI - Critical review of the methods used to measure the apparent dissociation constant and ligand purity in Ca2+ and Mg2+ buffer solutions JO - Prog Biophys Mol Biol VL - 92 UR - https://doi.org/10.1016/j.pbiomolbio.2006.05.001 DO - 10.1016/j.pbiomolbio.2006.05.001 ID - McGuigan2006 ER - TY - JOUR AU - Herbozo, P. J. AU - Briones, D. L. AU - Ferres, A. J. AU - Torrealba, R. L. PY - 2007 DA - 2007// TI - Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws JO - J Oral Maxillofac Surg VL - 65 UR - https://doi.org/10.1016/j.joms.2007.03.021 DO - 10.1016/j.joms.2007.03.021 ID - Herbozo2007 ER - TY - JOUR AU - Jeffcoat, M. AU - Watts, N. B. PY - 2008 DA - 2008// TI - Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis JO - Gen Dent VL - 56 ID - Jeffcoat2008 ER - TY - JOUR AU - Weitzman, R. AU - Sauter, N. AU - Eriksen, E. F. AU - Tarassoff, P. G. AU - Lacerna, L. V. AU - Dias, R. AU - Altmeyer, A. AU - Csermak-Renner, K. AU - McGrath, L. AU - Lantwicki, L. AU - Hohneker, J. A. PY - 2007 DA - 2007// TI - Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients-May 2006 JO - Crit Rev Oncol Hematol VL - 62 UR - https://doi.org/10.1016/j.critrevonc.2006.12.005 DO - 10.1016/j.critrevonc.2006.12.005 ID - Weitzman2007 ER - TY - JOUR AU - Landesberg, R. AU - Cozin, M. AU - Cremers, S. AU - Woo, V. AU - Kousteni, S. AU - Sinha, S. AU - Garrett-Sinha, L. AU - Raghavan, S. PY - 2008 DA - 2008// TI - Inhibition of oral mucosal cell wound healing by bisphosphonates JO - J Oral Maxillofac Surg VL - 66 UR - https://doi.org/10.1016/j.joms.2008.01.026 DO - 10.1016/j.joms.2008.01.026 ID - Landesberg2008 ER - TY - JOUR AU - Ottewell, P. D. AU - Woodward, J. K. AU - Lefley, D. V. AU - Evans, C. A. AU - Coleman, R. E. AU - Holen, I. PY - 2009 DA - 2009// TI - Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone JO - Mol Cancer Ther VL - 8 UR - https://doi.org/10.1158/1535-7163.MCT-09-0462 DO - 10.1158/1535-7163.MCT-09-0462 ID - Ottewell2009 ER - TY - JOUR AU - Guenther, A. AU - Gordon, S. AU - Tiemann, M. AU - Burger, R. AU - Bakker, F. AU - Green, J. R. AU - Baum, W. AU - Roelofs, A. J. AU - Rogers, M. J. AU - Gramatzki, M. PY - 2010 DA - 2010// TI - The bisphosphonate zoledronic acid has antimyeloma activity in vivo by inhibition of protein prenylation JO - Int J Cancer VL - 126 UR - https://doi.org/10.1002/ijc.24758 DO - 10.1002/ijc.24758 ID - Guenther2010 ER - TY - JOUR AU - Karabulut, B. AU - Erten, C. AU - Gul, M. K. AU - Cengiz, E. AU - Karaca, B. AU - Kucukzeybek, Y. AU - Gorumlu, G. AU - Atmaca, H. AU - Uzunoglu, S. AU - Sanli, U. A. AU - Baran, Y. AU - Uslu, R. PY - 2009 DA - 2009// TI - Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells JO - Cell Biol Int VL - 33 UR - https://doi.org/10.1016/j.cellbi.2008.11.011 DO - 10.1016/j.cellbi.2008.11.011 ID - Karabulut2009 ER - TY - JOUR AU - Ebert, R. AU - Zeck, S. AU - Krug, R. AU - Meissner-Weigl, J. AU - Schneider, D. AU - Seefried, L. AU - Eulert, J. AU - Jakob, F. PY - 2009 DA - 2009// TI - Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation JO - Bone VL - 44 UR - https://doi.org/10.1016/j.bone.2009.01.009 DO - 10.1016/j.bone.2009.01.009 ID - Ebert2009 ER - TY - JOUR AU - Sutherland, K. A. AU - Rogers, H. L. AU - Tosh, D. AU - Rogers, M. J. PY - 2009 DA - 2009// TI - RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro JO - Arthritis Res Ther VL - 11 UR - https://doi.org/10.1186/ar2681 DO - 10.1186/ar2681 ID - Sutherland2009 ER - TY - JOUR AU - Jefferson, K. K. AU - Goldmann, D. A. AU - Pier, G. B. PY - 2005 DA - 2005// TI - Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms JO - Antimicrob Agents Chemother VL - 49 UR - https://doi.org/10.1128/AAC.49.6.2467-2473.2005 DO - 10.1128/AAC.49.6.2467-2473.2005 ID - Jefferson2005 ER -